fig1
![Radiomics in sarcoma trials: a complement to RECIST for patient assessment](https://image.oaes.cc/317af1c3-7ae6-40da-bc00-a41e37eb9693/5217.fig.1.jpg)
Figure 1. Increasing the complexity of measurement can provide additional information about the tumor’s radiographic phenotype, beyond tumor size. With advances in computation and algorithms, this information could potentially augment existing response criteria.